Prakt. lékáren. 2006; 2(5): 227-228

Zelený čaj - zdroj cenných látek pro využití v terapii

doc. RNDr. Jiřina Spilková CSc1, PharmDr. Tomáš Siatka CSc2
1 _
2 -

Zelený čaj je součástí čínské a japonské kultury a životního stylu. Značnému zájmu jak spotřebitelů, tak i výzkumníků se těší i v jiných částech světa. Vliv zeleného čaje na zdraví člověka je podpořen výsledky několika epidemiologických studií a velkým počtem experimentů in vitro a na laboratorních zvířatech. Hlavním nositelem účinku je epigalokatechin galát (EGCG) díky jeho významné antioxidační aktivitě. Epidemiologickými studiemi bylo zaznamenáno příznivé působení zejména při kardiovaskulárním onemocnění.

Published: February 1, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Spilková J, Siatka T. Zelený čaj - zdroj cenných látek pro využití v terapii. Praktické lékárenství. 2006;2(5):227-228.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Bažata V. Izolovaný EGCG - vědecké zdůvodnění zdravotních tvrzení. Kongres s mezinárodní účastí Georg Joseph Camel (1661-1706), Brno, 8. 6. - 10. 6. 2006.
    2. Bruneton J. Pharmacognosy. Phytochemistry. Medicinal plants. Paris: Lavoisier Publishing 1999. 1075 s.
    3. Bun SS et al. Effect of green tea extracts on liver functions in Wistar rats. Food Chem Toxicol 2006; 44: 1108-1113. Go to original source... Go to PubMed...
    4. Cheng TO. All teas are not created equal: The Chinese green tea and cardiovascular health. Int J Cardiol 2006; 108: 301-308. Go to original source... Go to PubMed...
    5. Higdon VJ, Frei B. Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions. Crit Rev Food Sci Nutr 2003; 43: 89-143. Go to original source... Go to PubMed...
    6. Isbrucker RA, Bausch J, Edwards JA, Wolz E. Safety studies on epigallocatechin gallate (EGCG) preparations. Part 1: Genotoxicity. Food Chem Toxicol 2006; 44: 626-635. Go to original source... Go to PubMed...
    7. Isbrucker RA et al. Safety studies on epigallocatechin gallate (EGCG) preparations. Part 2: Dermal, acute and short-term toxicity studies. Food Chem Toxicol 2006; 44: 636-650. Go to original source... Go to PubMed...
    8. Isbrucker RA et al. Safety studies on epigallocatechin gallate (EGCG) preparations. Part 3: Teratogenicity and reproductive toxicity studies in rats. Food Chem Toxicol 2006; 44: 651-661. Go to original source... Go to PubMed...
    9. Rijken PJ et al. Antioxidant and other properties of green and black tea. In: Cadenas E, Packer L. (Eds). Handbook of antioxidants. New York, Basel: Marcel Dekker Inc. 2002. 371 s.
    10. Si W et al. Bioassay-guided purification and identification of antimicrobial components in Chinese green tea extract. J Chromatogr A 2006; 1125: 204-210. Go to original source... Go to PubMed...
    11. Sumpio BE et al. Green tea, the, ,Asian paradox", and cardiovascular disease. J Am Coll Surg 2006; 202: 813-825. Go to original source... Go to PubMed...
    12. Thangapazham RL et al. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo. Cancer Lett 2006; 1: 1-10. Go to original source...
    13. Valíček P a kol. Užitkové rostliny tropů a subtropů. Praha: Academia 2002: 260 s.
    14. Wang S, Noh SK, Koo SI. Green tea catechins inhibit pancreatic phospholipase A2 and intestinal absorption of lipids in ovariectomized rats. J Nutr Biochem 2006; 17: 492-498. Go to original source... Go to PubMed...
    15. Zaveri NT. Green tea and its polyphenolic catechins: Medicinal uses in cancer and noncancer applications. Life Sci 2006; 78: 2073-2080. Go to original source... Go to PubMed...

    Return to the content


    Pharmacy for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.